NCBI PubMed Central
open access
Brain PET in the era of anti-amyloid-β antibody therapy for Alzheimer disease.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Practice Effects and Amyloid Imaging Using 18F-PIB or Flutemetamol PET and FDG-PET#1044874
- Cerebral amyloid is associated with greater white-matter hyperintensity accrual in cognitively normal older adults#612033
- Deep sleep slow wave-spindle coupling is selectively linked to plasma amyloid-β levels in older adults in clinical trials#5497
- On the crossroads of interdisciplinary medicine in amyloidosis - study protocol for a single-center interdisciplinary registry study.#255305
- Tau PET Outcomes With Anti-amyloid Immunotherapies#279501
Record · ID 404271
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive